Analyst Ratings for Novo Nordisk (NVO)
NVO Rating Summary
NVO Price Target Summary
- Highest: $47.00 (Goldman Sachs)
- Lowest: $38.00 (CFRA)
- Average: $42.56
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$42.56 (+9.6%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
Avg. $ Target:
$42.56 (+9.6%)
* Over Last 12-Mos
Rating Score: 2.9 / 10
Percentile Rank: 24%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 9/22/2026 | CFRA | Wan Nurhayati | Downgrade | Sell (Hold) |
38.00 (N/A) |
39.80 (38.83) |
-2.44% | Details |
| 9/11/2026 | Morgan Stanley | Thibault Boutherin | Downgrade | Underweight (Equalweight) |
40.00 (N/A) |
44.56 (38.83) |
-12.86% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
